Samples collected by this study are analyzed by the Broad Institute under the leadership of Niall Lennon, Ph.D.
Dr. Lennon is the senior director of translational genomics at the Broad Institute of MIT and Harvard, where he is also an institute scientist and chair of Broad’s clinical testing laboratory. Dr. Lennon is also an associate director of the Gerstner Center for Cancer Diagnostics. He oversees the development, implementation, and validation of technologies to serve basic research, clinical research, and clinical diagnostics.
Dr. Lennon has been with the Broad since 2006 and has contributed to the development of applications for every major sequencing platform. He also built a CLIA/CAP licensed clinical laboratory at the Broad to facilitate return of results to patients and to support clinical trials. More recently, Dr. Lennon has led efforts to achieve FDA approval for both large-scale genomics projects (NIH’s All of Us program) and for Broad’s own clinical diagnostic for COVID-19 testing process that has delivered millions of diagnostic test results.